Polpharma Biologics Integrates Bioceros

Company Plans To Retire The Bioceros Name Thereafter

Polpharma Biologics is making strategic moves to become a truly integrated CDMO by bringing its Dutch Bioceros subsidiary under the Polpharma Biologics brand.

Integration
Polpharma Biologics has fully integrated Bioceros and its proprietary cell line development platform • Source: Shutterstock

Polpharma has announced the integration of its Dutch Bioceros subsidiary under the Polpharma Biologics banner, to become “a truly integrated CDMO, offering the complete spectrum of services from discovery to commercial supply.”

The company plans to retire the Bioceros name as it brings Bioceros and its proprietary cell line development platform CHOBC...

Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Strategy

More from Business